Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Surveillance & Reporting

On This Page

Trends

Pertussis is nationally-notifiable and cases should be reported to the appropriate health department. Pertussis cases are reported by states to CDC through the National Notifiable Diseases Surveillance System (NNDSS). Although many pertussis cases are not diagnosed and therefore not reported, the surveillance system is useful for monitoring epidemiologic trends. The limitations of laboratory diagnostics make the clinical case definition essential to pertussis surveillance. It is important to determine duration of cough — specifically whether it lasts 14 days or longer — in order to determine if a person's illness meets the definition of a clinical case.

This line chart depicts reported pertussis incidence by age group for reporting period 1990-2011. Detailed text description follows this figure. View Larger Image

This graph shows reported pertussis incidence (per 100,000 persons) by age group in the United States from 1990-2011. Infants aged <1 year, who are at greatest risk for severe disease and death, continue to have the highest reported rate of pertussis. While adolescents (aged 11–19 years) and adults (aged >20 years) accounted for approximately 47% of reported cases in 2011, persons aged 7-10 years continued to contribute a significant proportion of cases (18%).

This line chart depicts U.S. reported pertussis incidence for reporting period 1990-2011. Detailed text description follows this figure.View Larger Image

This graph shows incidence per 100,000 persons of reported pertussis in the United States from 1990-2011. The overall incidence of pertussis peaked most recently in 2010, and rates declined nationally during 2011.

Case Definition

Pertussis cases are reported by states to CDC through the National Notifiable Diseases Surveillance System (NNDSS). Both probable and confirmed cases should be reported nationally. The most recent case definition (1997) for pertussis includes the following information:

Clinical Case Definition

Year Reported Cases*
2000 7,867
2001 7,580
2002 9,771
2003 11,647
2004 25,827
2005 25,616
2006 15,632
2007 10,454
2008 13,278
2009 16,858
2010 27,550
2011* 18,719

*Total reported cases include those with unknown age.

A cough illness lasting at least 2 weeks with one of the following: paroxysms of coughing, inspiratory "whoop," or posttussive vomiting, without other apparent cause (as reported by a health professional).

This clinical case definition is appropriate for endemic or sporadic cases. In outbreak settings, a case may be defined as a cough illness lasting at least 2 weeks (as reported by a health professional).

Laboratory Criteria for Diagnosis

  • Isolation of Bordetella pertussis from clinical specimen
  • Positive polymerase chain reaction (PCR) for B. pertussis

Because direct fluorescent antibody testing of nasopharyngeal secretions has been demonstrated in some studies to have low sensitivity and variable specificity, such testing should not be relied on as a criterion for laboratory confirmation. Serologic testing for pertussis is available in some areas but is not standardized and, therefore, should not be relied on as a criterion for laboratory confirmation.

Case Classification

Probable: meets the clinical case definition, is not laboratory confirmed, and is not epidemiologically linked to a laboratory-confirmed case.

Confirmed: a case that is confirmed culture positive and in which an acute cough illness of any duration is present; or a case that meets the clinical case definition and is confirmed by positive PCR; or a case that meets the clinical case definition and is epidemiologically linked directly to a case confirmed by either culture or PCR.

Enhanced Pertussis Surveillance (EPS)

CDC has partnered with six states (CO, CT, MN, NM, NY, and OR) participating in the Emerging Infections Program (EIP) network to conduct enhanced surveillance of pertussis and other Bordetella species. EPS is characterized by enhanced case ascertainment and augmented data collection that goes beyond what is requested nationally through NNDSS. Participating sites collect isolates and specimens, when available, for further characterization at the CDC Pertussis and Diphtheria Laboratory. EPS sites also provide the infrastructure for conducting pertussis special studies including those aimed at evaluating pertussis prevention and control strategies.

 

Top of Page

 

Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more

External Web Site Policy This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • New Hours of Operation
    8am-8pm ET/Monday-Friday
    Closed Holidays
  • cdcinfo@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - cdcinfo@cdc.gov
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #